Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Solid-phase synthesis of CD40L mimetics.

Alberto Bianco1, Sylvie Fournel, Sébastien Wieckowski

  • 1Institut de Biologie Moléculaire et Cellulaire, UPR 9021 CNRS, Immunologie et Chimie Thérapeutiques, 15 Rue René Descartes, 67084 Strasbourg, France. A.Bianco@ibmc.u-strasbg.fr

Organic & Biomolecular Chemistry
|April 11, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A pH-responsive double network hydrogel for control of tomato bacterial wilt.

Nature communications·2026
Same author

Decoding Carbon Dot Purity by Nuclear Magnetic Resonance.

Angewandte Chemie (International ed. in English)·2026
Same author

Multifunctional amino acid-based nanoparticles for sequential drug delivery to overcome multidrug resistant cancer.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Turning Unpredictable Biomolecule Adsorption to Controlled Corona Formation: Focus on Carbon Nanomaterials.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

A pH/ROS dual-responsive metal-polyphenol-antibiotic nano-assembly for combating persistent infection by overcoming biofilm and cell membrane barriers.

Biomaterials·2026
Same author

Polyglutamate-loaded chitosan nanogels reprogram plant metabolism for increased growth and viral resistance.

Nature communications·2026
Same journal

Sulfonamides: a decade of development in synthetic methods and biological activity studies.

Organic & biomolecular chemistry·2026
Same journal

TBAF-promoted dephenolative transcarbomylation: direct access to substituted carbamates & thiocarbamates.

Organic & biomolecular chemistry·2026
Same journal

Catalytic synthesis of saturated azacycles using transborylation.

Organic & biomolecular chemistry·2026
Same journal

Pyridines with adamantane fragments and their 1,2,4-triazine analogues as anti-quorum-sensing agents, synthesis and molecular docking.

Organic & biomolecular chemistry·2026
Same journal

Synthesis of polymethylene-linked bis(cyclobutane-fused chromanones) mediated by gold photocatalysis.

Organic & biomolecular chemistry·2026
Same journal

Palladium-catalyzed chelation-assisted C-H functionalization of quinoline aldehydes to esters with mechanistic insights.

Organic & biomolecular chemistry·2026
See all related articles

Researchers developed a novel cyclic hexapeptide molecule that mimics CD40 ligand (CD40L) homotrimers. This molecule effectively binds to CD40 and exhibits important effector functions for potential therapeutic applications.

Area of Science:

  • Biochemistry
  • Immunology
  • Medicinal Chemistry

Background:

  • CD40 ligand (CD40L) homotrimers are crucial for immune responses.
  • Mimicking CD40L's structure and function is a therapeutic strategy.
  • Previous studies showed C3-symmetric molecules can mimic CD40L.

Purpose of the Study:

  • To describe a general solid-phase synthesis approach for C3-symmetric molecules.
  • To evaluate the CD40 binding properties of these molecules.
  • To assess the effector functions of the synthesized trimeric architectures.

Main Methods:

  • Solid-phase synthesis of cyclic hexapeptides.
  • Modification of lysine side chains with CD40L-derived sequences.
  • Assessment of CD40 binding affinity and effector function assays.

Related Experiment Videos

Main Results:

  • A generalizable solid-phase synthesis method was established.
  • The synthesized C3-symmetric molecules demonstrated CD40 binding.
  • Evaluated effector functions confirmed the molecule's biological activity.

Conclusions:

  • The developed synthesis approach allows for the creation of novel CD40L mimics.
  • These molecules show promise as CD40 agonists with potential therapeutic value.
  • Further investigation into their immunomodulatory effects is warranted.